Search Results - "Royer, Jimmy"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    The Effect of Quebec’s CEGEPs on Total Years of Schooling by FORTIN, PIERRE, MISHAGINA, NATALIA, ROYER, JIMMY

    Published in Canadian public policy (01-09-2022)
    “…Nous décrivons la réforme collégiale des années 1960 au Québec et nous étudions l’effet initial de la création des cégeps sur la scolarisation des jeunes…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance prediction by Chen, Michael L., Doddi, Akshith, Royer, Jimmy, Freschi, Luca, Schito, Marco, Ezewudo, Matthew, Kohane, Isaac S., Beam, Andrew, Farhat, Maha

    Published in EBioMedicine (01-05-2019)
    “…The diagnosis of multidrug resistant and extensively drug resistant tuberculosis is a global health priority. Whole genome sequencing of clinical Mycobacterium…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    L’effet des cégeps du Québec sur le nombre total d’années de scolarité by FORTIN, PIERRE, MISHAGINA, NATALIA, ROYER, JIMMY

    Published in Canadian public policy (01-09-2022)
    “…Nous décrivons la réforme collégiale des années 1960 au Québec et nous étudions l’effet initial de la création des cégeps sur la scolarisation des jeunes…”
    Get full text
    Journal Article
  12. 12

    The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation by Cutler, David M, Long, Genia, Berndt, Ernst R, Royer, Jimmy, Fournier, Andree-Anne, Sasser, Alicia, Cremieux, Pierre

    Published in Health Affairs (01-01-2007)
    “…Using national survey data and risk equations from the Framingham Heart Study, we quantify the impact of antihypertensive therapy changes on blood pressures…”
    Get full text
    Journal Article
  13. 13

    Beyond multidrug resistance: Leveraging rare variants with machine and statistical learning models in Mycobacterium tuberculosis resistance predictionResearch in context by Michael L. Chen, Akshith Doddi, Jimmy Royer, Luca Freschi, Marco Schito, Matthew Ezewudo, Isaac S. Kohane, Andrew Beam, Maha Farhat

    Published in EBioMedicine (01-05-2019)
    “…Background: The diagnosis of multidrug resistant and extensively drug resistant tuberculosis is a global health priority. Whole genome sequencing of clinical…”
    Get full text
    Journal Article
  14. 14

    Is backdating executive stock options always costly to shareholders? by Grégoire, Philippe, Glenn Hubbard, Robert, Koehn, Michael F., Audenrode, Marc Van, Royer, Jimmy

    Published in Accounting and finance (Parkville) (01-09-2013)
    “…We use a binomial model to investigate the cost to shareholders of backdating employee stock option (ESO) grants to award in‐the‐money rather than at‐the‐money…”
    Get full text
    Journal Article
  15. 15

    The economic impact of a partnership-measurement model of disease management: Improving Cardiovascular Outcomes in Nova Scotia (ICONS) by Crémieux, Pierre-Yves, Fortin, Pierre, Meilleur, Marie-Claude, Montague, Terrence, Royer, Jimmy

    “…Improving Cardiovascular Outcomes in Nova Scotia (ICONS) was a five-year, community partnership-based disease-management project that sought, as a primary…”
    Get more information
    Journal Article